Regeneron Pharmaceuticals reported $2.07B in Cash and Equivalent for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acceleron Pharma XLRN:US $ 336.2M 119.31M
Agenus AGEN:US $ 73.54M 45.82M
Agios Pharmaceuticals AGIO:US $ 969.12M 918.9M
Alexion Pharmaceuticals ALXN:US $ 3429.6M 465.1M
Alimera Sciences ALIM:US $ 24.78M 16.51M
Alnylam Pharmaceuticals ALNY:US $ 745.77M 366.22M
Amgen AMGN:US $ 6630M 518M
Astellas Pharma 4503:JP Y 301920M 24208M
AstraZeneca AZN:LN 15567M 7931M
Biogen BIIB:US $ 1742M 524.5M
Biomarin Pharmaceutical BMRN:US $ 641.53M 25.78M
Bluebird Bio BLUE:US $ 353.47M 86.25M
Bristol Myers Squibb BMY:US $ 11024M 42M
Eli Lilly And LLY:US $ 3220M 217.6M
Esperion Therapeutics ESPR:US $ 219.19M 1.25M
Gilead Sciences GILD:US $ 7361M 3296M
GlaxoSmithKline GSK:LN 3503M 1254M
Intercept Pharmaceuticals ICPT:US $ 145.62M 52.67M
IONIS PHARMACEUT IONS:US $ 565.12M 150.96M
Kyowa Hakko Kirin 4151:JP Y 292762M 8999M
Moderna Inc MRNA:US 5.6B 161M
Neurocrine Biosciences NBIX:US $ 368M 15.4M
Novartis NOVN:VX SF 5117M 1316M
Novartis NVS:US $ 5117M 1316M
Opthea Ltd OPT:AU 118.19M 73.75M
Puma Biotechnology PBYI:US $ 89.85M 5.8M
Regeneron Pharmaceuticals REGN:US $ 2072.2M 634.3M
Sarepta Therapeutics SRPT:US $ 1697.28M 215.44M
Seattle Genetics SGEN:US $ 413.43M 39.72M
Teva Pharmaceutical TEVA:IT 2.44B 693M
Ultragenyx Pharmaceutical RARE:US $ 290.88M 92.92M
United Therapeutics UTHR:US $ 942.2M 109.9M
Vertex Pharmaceuticals VRTX:US $ 6063.68M 240.65M
YTE INCY:US $ 1797.58M 127.61M